Description: BCAL Diagnostics Limited, a biotechnology company, engages in developing a non-invasive laboratory blood test for the detection of breast cancer. It develops BCAL test, a lipid biomarker blood test with the potential to be used for breast cancer prevention, screening, and monitoring. The company was founded in 2010 and is based in Sydney, Australia.
Home Page: www.bcaldiagnostics.com
BDX Technical Analysis
50 Clarence Street
Sydney,
NSW
2000
Australia
Phone:
61 2 9078 7671
Officers
| Name | Title |
|---|---|
| Ms. Jayne Andrea Shaw | Co-Founder & Exec. Chairman |
| Dr. John G. Hurrell B.Sc, Fulbright Fel, M.Sc(Qual), Ph.D. | Chief Exec. Officer |
| Hon. Ronald Anthony Phillips A.O. | Co-Founder & Non-Exec. Director |
| Dr. Amani Batarseh Ph.D. | Chief Scientist Officer |
| Mr. Guy Adrian Robertson B.Com., B.Comm(Hons.), C.A., CA, MAICD | CFO & Company Sec. |
| Dr. Jane Ryan Bsc (Hons), M.A.I.C.D., Ph.D. | Chief Operating Officer |
| Sean Kennedy | Director of Corp. Fin. |
| Ms. Rebecca Shaw | Marketing Mang. |
Exchange: AU
Country: AU : Australia
Currency: Australian Dollar (A$)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 1.5793 |
| Price-to-Sales TTM: | 17.9472 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 0 |